Showing results (701-710 of 4,010) with videos related to
Sort By:
Pageof 401
Global & Regional Health Technology Assessment|January 11, 2023
Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia BAndrea Aiello, Maria E Mancuso, Alessio Colombo, et al.Value in Health Regional Issues|May 20, 2019
Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean PerspectiveEleonora Aiello, Pablo Manuel Bianculli, Devarshi Bhattacharyya, et al.Case Reports in Dentistry|October 11, 2021
Can Orthodontic Treatment Be Stable 20 Years after the End of the Treatment Scheme? Treatment of a Class 2, Division 1 Malocclusion with Severe Skeletal Discrepancy and Its 20-Year Follow-UpDomenico Aiello, Riccardo Nucera, Stefania Costa, et al.Expert Review of Clinical Immunology|July 25, 2022
An immunologist's guide to immunosenescence and its treatmentCalogero Caruso, Mattia Emanuela Ligotti, Giulia Accardi, et al.Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|September 11, 2004
Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shuntsRubens Fraga Alves Pinto, Maria de Lourdes Higuchi, Vera Demarchi AielloInternational Journal of Cardiology|August 1, 2006
Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertensionGian Paolo Ussia, Massimiliano Mulè, Elio Caruso, et al.British Journal of Pharmacology|June 1, 1991
CGP 35348, a new GABAB antagonist, prevents antinociception and muscle-relaxant effect induced by baclofenM Malcangio, C Ghelardini, A Giotti, et al.Acta Endocrinologica|October 1, 1976
Action of KI, thyroxine and cyclic AMP on [3H]uridine incorporation into the RNA of thyroid slicesM A Pisarev, L O Aiello, D L Kleiman de PisarevActa Gastroenterologica Latinoamericana|December 11, 2012
[An adapted model of cost-effectiveness analysis for the drug entecavir vs pegylated interferon in Venezuela]John Jairo Orozco Giraldo, Juan Esteban Valencia, Eleonora Aiello, et al.Cell Death and Differentiation|March 9, 2013
The loss of the BH3-only Bcl-2 family member Bid delays T-cell leukemogenesis in Atm-/- miceS Biswas, Q Shi, A Wernick, et al.Pageof 401